Search Results
You are looking at 1 - 2 of 2 items for
- Author: Chang Yoon Lee x
- Refine by access: All content x
Search for other papers by Sung Gwe Ahn in
Google Scholar
PubMed
Search for other papers by Chang Ik Yoon in
Google Scholar
PubMed
Search for other papers by Jae Hoon Lee in
Google Scholar
PubMed
Search for other papers by Hye Sun Lee in
Google Scholar
PubMed
Search for other papers by So Eun Park in
Google Scholar
PubMed
Search for other papers by Yoon Jin Cha in
Google Scholar
PubMed
Search for other papers by Chihwan Cha in
Google Scholar
PubMed
Search for other papers by Soong June Bae in
Google Scholar
PubMed
Search for other papers by Kyung-A Lee in
Google Scholar
PubMed
Search for other papers by Joon Jeong in
Google Scholar
PubMed
On the basis of TP53 mutations and standardized uptake values (SUVs) from 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET), we sought to enhance our knowledge of the biology underlying low progesterone receptor (PR) expression in estrogen receptor (ER)-positive/human epidermal growth factor receptor-2 (HER2)-negative tumors. This study included 272 patients surgically treated for ER-positive, HER2-negative breast cancer and who had undergone TP53 gene sequencing. Of these, 229 patients also underwent 18F-FDG PET or PET/CT. Mutational analysis of exons 5–9 of the TP53 gene was conducted using PCR amplification and direct sequencing. The SUVs were measured using 18F-FDG-PET scan images. Twenty-eight (10.3%) tumors had a somatic TP53 mutation. The TP53 mutation rate was significantly higher in low-PR tumors than in high-PR tumors (17.1% vs 7.9%, P = 0.039). Low-PR tumors had significantly higher median SUVs than high-PR tumors (P = 0.046). The multivariable analysis revealed that SUV and age remained independent variables associated with low PR expression. An adverse impact of low PR expression on recurrence-free survival was observed in the multivariable Cox regression hazard model. We provide clinical evidence that genetic alteration of the TP53 gene and dysregulated glucose metabolism partly involve low PR expression in ER-positive and HER2-negative breast cancer.
Search for other papers by Seog Yun Park in
Google Scholar
PubMed
Search for other papers by Yuh-S Jung in
Google Scholar
PubMed
Search for other papers by Chang Hwan Ryu in
Google Scholar
PubMed
Search for other papers by Chang Yoon Lee in
Google Scholar
PubMed
Search for other papers by You Jin Lee in
Google Scholar
PubMed
Search for other papers by Eun Kyung Lee in
Google Scholar
PubMed
Search for other papers by Seok-Ki Kim in
Google Scholar
PubMed
Search for other papers by Tae Sung Kim in
Google Scholar
PubMed
Search for other papers by Tae Hyun Kim in
Google Scholar
PubMed
Search for other papers by Jeyun Jang in
Google Scholar
PubMed
Search for other papers by Daeyoon Park in
Google Scholar
PubMed
Search for other papers by Seung Myung Dong in
Google Scholar
PubMed
Search for other papers by Jae-Goo Kang in
Google Scholar
PubMed
Search for other papers by Jin Soo Lee in
Google Scholar
PubMed
Search for other papers by Junsun Ryu in
Google Scholar
PubMed
We undertook this study to estimate an accurate incidence and spread patterns of occult papillary thyroid carcinoma (PTC) in patients with a preoperative diagnosis of solitary PTC by using whole-specimen mapping of all specimens after a total thyroidectomy. Enrolled prospectively in this whole-thyroid mapping study are 82 consecutive patients who underwent a total thyroidectomy under a preoperative diagnosis of solitary PTC. All thyroidectomy specimens were serially sectioned in 2 mm thickness and whole-thyroid mapping was carried out for additional foci of occult PTC. The frequencies of occult lesions detected in the whole and contralateral lobe were determined, and clinicopathologic factors associated with multifocality were assessed. Whole-thyroid mapping revealed 66 occult PTC lesions missed by preoperative ultrasound in 37 (45.1%) of the 82 patients. The great majority (92.5%) of the occult PTC was smaller than 3 mm in size and 25 patients (30.5%) had contralateral lesions. We found that the male sex was an independent predictor of multifocality (odds ratio (OR), 3.00; 95% CI, 1.11–8.14), adjusting for preoperative findings. Analysis with pathologic parameters showed that the male sex (OR, 5.03; 95% CI, 1.68–15.08) and extrathyroidal extensions (OR, 3.03; 95% CI, 1.03–8.95) were associated with multifocal PTC. However, none of the clinicopathologic factors evaluated predicted contralateral PTC. Our study demonstrates the diagnostic limitations of ultrasound for the detection of multifocal PTC and the need to consider the possibility of occult lesions in the management of solitary PTC, especially in male patients.
